Thalassemia in the next millennium

Annals of the New York Academy of Sciences

Volumn 850, Issue , 1998, Pages 1-9

  Weatherall, D J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; HEMOGLOBIN F; HEMOGLOBIN E;

BETA THALASSEMIA; CONFERENCE PAPER; COOPERATION; DEVELOPING COUNTRY; GENE FREQUENCY; GOVERNMENT; HEALTH CARE; HETEROZYGOTE DETECTION; HUMAN; PHENOTYPE; PRENATAL DIAGNOSIS; PUBLIC HEALTH; SOUTHERN EUROPE; THALASSEMIA; ARTICLE; FEMALE; FORECASTING; GENETIC COUNSELING; GENETICS; HEALTH; MALARIA; POPULATION GENETICS; PREGNANCY; PREVALENCE;

BETA-THALASSEMIA; FEMALE; FORECASTING; GENE FREQUENCY; GENETIC COUNSELING; GENETICS, POPULATION; HEMOGLOBIN E; HUMANS; MALARIA; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; WORLD HEALTH;

EID: 0031822090     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10456.x     Document Type: Conference Paper

References (21)

1. AD HOC COMMITTEE ON HEALTH RESEARCH RELATING TO FUTURE INTEVENTION OPTIONS. 1996 World Health Organization, Geneva.
2. THE WORLD BANK. 1993 World Development Report. Investing in Health. Oxford University Press, Oxford.
3. WEATHERALL, D. J. & J. B. CLEGG. 1996. Thalassemia - A global public health problem. Nature Med. 2: 847-849.
4. FAWDRY, A. L. 1944 Erythroblastic anaemia of childhood (Cooley's) anaemia in Cyprus. Lancet i: 171-176
5. WHO WORKING GROUP ON THE COMMUNITY CONTROL OF HEREDITARY ANAEMIAS. 1983. Bull. World Health Organ. 61: 63-80
6. WASI, P., S. NA-NAKORN, S. POOTRAKUL, M. SOOKANEK et al. 1969. Alpha- and beta-thalassemia in Thailand. Ann. N.Y. Acad. Sci 165: 60-82.
7. FLINT, J., R. M. HARDING, A. J. BOYCE & J. B. CLEGG. 1993. The population genetics of the haemoglobinopathies. Clin. Haematol. 6: 215-262.
8. FLINT, J., A. V. S. HILL, D. K.BOWDEN, S. J. OPPENHEIMER et al. 1986. High frequencies of α thalassaemia are the result of natural selection by malaria. Nature 321: 744-750.
9. ALLEN, S. J., A. O'DONNELL, N. D. E. ALEXANDER, M. P. ALPERS et al. 1997. α thalassemia protects children against disease due to malaria and other infections. Proc. Natl. Acad. Sci. USA 94: 14736-14741.
10. WILLIAMS, T. N., K. MAITLAND, S. BENNETT, M. GANCZAKOWSKI et al. 1996. High incidence of malaria in a-thalassaemia children. Nature 383: 522-525.
11. HILL, A. V. S. 1996. Genetics of infectious disease resistance. Curr. Opin. Genet. Dev. 6: 348-353.
12. MCGUIRE, W., A. V. S. HILL, C. E. M. ALLSOPP, B. M. GREENWOOD et al. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-511.
13. MILLER, L. H. 1994. Impact of malaria on genetic polymorphism and genetic diseases in Adricans and African Americans. Proc. Natl. Acad. Sci. USA. 91: 2415-2419.
14. WEATHERALL, D. J. 1995. The molecular basis for phenotypic variability of the common thalassaemias. Mol. Med. Today 1: 15-20.
15. WEATHERALL, D. J. 1994. Thalassemia. In The Molecular Basis of Blood Diseases, 2nd edit. S. STAMATOYANNOPOULOS, A. W. NIENHUIS, P. W. MAJERUS & H. VARMUS, Eds.: 157-206. W.B. Saunders Company, Philadelphia.
16. DOVER, G. J., K. D. SMITH, Y. C. CHANG, S. PURVIS et al. 1992 Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 80: 816-824.
17. CRAIG, J. E., J. ROCHETTE, C. A. FISHER, D. J. WEATHERALL et al. 1996. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nature Genet. 12: 58-64.
18. HUISMAN, T. H. J. 1993. The structure and function of normal and abnormal haemoglobins. Clin. Haematol. 6: 1-30.
19. Cao, A. & Rosatelli, M. C. 1993. Screening and prenatal diagnosis of the haemoglobin-mopathies. Semin. Hematol. 33: 263-286.
20. OLIVIERI, N. F. 1995. Clinical experience with reactivation of fetal hemoglobin in the beta hemoglobinopathies. Semin. Hematol. 33: 24-42.
21. OLIVIERI, N. F., D. C. REES, G. D. GINDER, S. L. THEIN et al. 1997. Treatment of thalassaemia major with phenylbutyrate and hydroxyurea. Lancet 350: 491-492.